Company
Fifty 410
Fifty 410 publishes compounded tirzepatide and compounded semaglutide, from $133 to $199 a month. The lowest requires a 3-month plan.
- 2 programs
- 2 molecules
- 2 readings
Read from fifty410.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Fifty 410
We earn nothing from this link. Fifty 410 has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · $399 charged today · Starter Program, 3-month
first month, including the required fees on record · Monthly
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Explicitly no membership fee: 'There is no membership fee' and 'When am I charged? Only if a provider issues a prescription... There is no membership fee.' Both products are described only as 'administered by subcutaneous injection' without ever specifying vial vs. pen, so form is not-disclosed rather than assumed.
Before you act
Cite this
Treatment Registry. (2026). Fifty 410: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/fifty-410